HPV Vaccine (Gardasil 9) from United States
A recombinant vaccine that prevents human papillomavirus infections, which can cause cervical cancer and warts. It is a vaccine for human medicine, classified under tariff item 3002.41.00 as a prophylactic preparation.
Duty Rate — United States → Canada
0%
Import Tips
• Ensure the vaccine has a Health Canada Notice of Compliance (NOC) and is listed in the Canadian Drug Product Database
• Prepare a detailed commercial invoice and packing list for CBSA clearance, including the vaccine's cold chain documentation